Hallmarks of Splicing Defects in Cancer: Clinical Applications in the Era of Personalized Medicine
Alternative splicing promotes proteome diversity by using limited number of genes, a key control point of gene expression. Splicing is carried out by large macromolecular machineries, called spliceosome, composed of small RNAs and proteins. Alternative splicing is regulated by splicing regulatory &l...
Main Authors: | Mohammad Alinoor Rahman, Farhana Nasrin, Sonali Bhattacharjee, Saikat Nandi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/6/1381 |
Similar Items
-
Editorial: Therapeutic targeting of splicing variants in cancer
by: Pouya Sarvari, et al.
Published: (2023-05-01) -
Identification of SL addition trans-splicing acceptor sites in the internal transcribed spacer I region of pre-rRNA in Leishmania (Leishmania) amazonensis
by: Mario Gustavo Mayer, et al.
Published: (2012-12-01) -
Disclosing the Impact of Carcinogenic SF3b Mutations on Pre-mRNA Recognition Via All-Atom Simulations
by: Jure Borišek, et al.
Published: (2019-10-01) -
Identification of a small molecule inhibitor that stalls splicing at an early step of spliceosome activation
by: Anzhalika Sidarovich, et al.
Published: (2017-03-01) -
A Quality Control Mechanism of Splice Site Selection Abrogated under Stress and in Cancer
by: Maram Arafat, et al.
Published: (2022-03-01)